CoChat
Sign Up
Cited by 94Cervical Cancer and HPV ResearchVaccine Coverage and HesitancyWomen's cancer prevention and management

Human papillomavirus infection and vaccination: awareness and knowledge of HPV and acceptability of HPV vaccine among mothers of teenage daughters in Weihai, Shandong, China

Open access
Yu, Yang, Xu, Minglei, Sun, Jiandong, Li, Ruiying, Li, Meilan, Wang, Jianguang, Zhang, Dongfeng, Xu, Aiqiang·2016·PLOS ONE
DOI 10.1371/journal.pone.0146741PMC PMC4713086
Open this paper in CoChat — free accountOpen PDF

Abstract

In preparation for the introduction of human papillomavirus (HPV) vaccine, we investigated awareness and knowledge of HPV/HPV vaccine and potential acceptability to HPV vaccine among mothers with a teenage daughter in Weihai, Shandong, China. A cross-sectional survey was conducted in 2013 with a sample of 1850 mothers who had a daughter (aged 9-17 years) attending primary, junior and senior high schools. In the final sample (N = 1578, response rate 85.30%), awareness of HPV was reported by 305 (19.32%) mothers. Awareness varied significantly by daughter's age (P<0.01), mother's education level (P<0.01), mother's occupation (P<0.01), household income (P<0.01) and residence type (P<0.01). Knowledge about HPV/HPV vaccine was poor with a mean total score of 3.56 (SD = 2.40) out of a possible score of 13. Mothers with a higher education level reported higher levels of knowledge (P = 0.02). Slightly more than one-fourth (26.49%) of mothers expressed their potential acceptability of HPV vaccine for their daughters. Acceptability increased along with increased daughters' age (P<0.01), household income (P<0.01) and knowledge level (P<0.01). House wives and unemployed mothers had the highest acceptability (P<0.01). The most common reasons for not accepting HPV vaccination were "My daughter is too young to have risk of cervical cancer (30.95%)", "The vaccine has not been widely used, and the decision will be made after it is widely used (24.91%)", "Worry about the safety of the vaccine (22.85%)". Awareness and knowledge of HPV/HPV vaccines are poor and HPV vaccine acceptability is low among these Chinese mothers. These results may help inform appropriate health education programs in this population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0146741

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HPV vaccine acceptance in this rural Mysore population was higher than reported among parents in other regions of India (46-74%) and other south Asian countries (26.5-84.0%).

    “There was a higher rate of HPV vaccine acceptance in this population as compared to that reported among parents in the other regions of India (Range: 46% to 74%) 13,14,22 and other countries in south Asia (Range: 26.5% to 84.0%).23-26”

    From Human Papillomavirus Vaccine Acceptability among Parents of Adolescent Girls in a Rural Area, Mysore, India (2018) · cites this paper as [25]

    The Discussion reports 26.5% potential HPV vaccine acceptability among mothers in Weihai, Shandong, China, supporting the lower endpoint of the cited range. But China is not in South Asia, so this source does not support classifying its population as from a South Asian country. The other citations may account for the rest of the range. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. [2]Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, et al Perceptions and acceptability of HPV vaccination among parents of young adolescents: A multicenter national survey in China. Vaccine, 2013, 31 (2013): 3244– 3249. 10.1016/j.vaccine.2013.05.046. 23707446 · DOI
  2. [3]Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med, 2003, 127(8): 930– 934.. 12873163
  3. [4]Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine, 2005, S1: 4– 10. 10.1016/j.vaccine.2005.09.054. 16406226 · DOI
  4. [5]Franco E, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine, 2005, 23(17–18): 2388– 2394. 10.1016/j.vaccine.2005.01.016. 15755633 · DOI
  5. [6]Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med, 2003, 348(6): 518– 527. 10.1056/NEJMoa021641. 12571259 · DOI · Paper page
  6. [7]Marlow Laura A.V., Zimet Gregory D., McCaffery Kirsten J., Ostini Remo, Waller Jo. Knowledge of human papillomavirus (HPV) and HPV vaccination: An international comparison. Vaccine, 2013, 31(2013): 763– 769. 10.1016/j.vaccine.2012.11.083. 23246310 · DOI
  7. [8]Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 2004, 111(2): 278– 285. 10.1002/ijc.20244. 15197783 · DOI
  8. [9]Bryan JT. Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine, 2007, 25(16): 3001– 3006. 10.1016/j.vaccine.2007.01.013. 17289220 · DOI
  9. [10]Dochez C, Bogers JJ, Verhelst R, Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine, 2014, 32(2014): 1595– 1601. 10.1016/j.vaccine.2013.10.081. 24606637 · DOI
  10. [11]Marek E, Dergez T, Rebek-Nagy G, Szilard I, Kiss I, Ember I, et al Effect of an educational intervention on Hungarian adolescents’ awareness, beliefs and attitudes on the prevention of cervical cancer. Vaccine, 2012, 30(2012): 6824– 6832. 10.1016/j.vaccine.2012.09.012. 23000124 · DOI
  11. [12]Bowyer HL, Marlow LAV, H Sam, Pollock KG, W Jo. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine, 2013, 31(2013): 1051– 1056. 10.1016/j.vaccine.2012.12.038. 23277094 · DOI
  12. [14]Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13–17 years-United States, 2007. MMWR Morb Mortal Wkly Rep, 2008, 57(40): 1100– 1103.. 18846032
  13. [17]Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S, et al Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine, 2011, 29(2011): 8591– 8598. 10.1016/j.vaccine.2011.09.018. 21939711 · DOI
  14. [19]Wei MX, Li SW, Huang B, Shen WT, Su YZ, Zhang CH, et al Production of human papillomavirus type 16 virus-like particles and its immunogenicity. Bing Du Xue Bao. 2009, 25: 245– 250.. 19769155
  15. [20]Xie M, Li S, Shen W, Li Z, Zhuang Y, Mo X, et al Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli. Sheng Wu Gong Cheng Xue Bao, 2009, 25: 1082– 1087.. 19835152
  16. [21]Lee PW, Kwan TT, Tam KF, Chan KK, Young PM, Lo SS, et al Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med, 2007, 45: 130– 134. 10.1016/j.ypmed.2007.07.013. 17707077 · DOI
  17. [22]Lenselink CH, Gerrits MM, Melchers WJ, Massuger LF, van Hamont D, Bekkers RL, et al Parental acceptance of human papilloma virus vaccines. EurJ Obstet Gynecol ReprodBiol 2008, 137: 103– 107. 17368910
  18. [23]Qiao YL, Franceschi S, Belinson JL. HPV Prevalence in Chinese women: a population-based multiple center survey in mainland China. Abstract Book, 24th International Papillomavirus Conference and Clinical Workshop, November 3–9, 2007, 1B-01:13.
  19. [24]Zhao FH, Tiggelaar SM, Hu SY, Xu LN, Hong Y, Niyazi M, et al A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papilloma virus vaccination in China. Cancer Epidemiol, 2012, 36: 384– 390. 10.1016/j.canep.2012.01.009 22377277 PMC5523958 · DOI
  20. [25]Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine, 2011, 29:(44) 7785– 7793. 10.1016/j.vaccine.2011.07.107. 21821079 · DOI · Paper page
  21. [26]Chen B, Zhang JM, Jiang Z, Shao J, Jiang T, Wang Z, et al Media and public reactions toward vaccination during the 'hepatitis B vaccine crisis' in China. Vaccine, 2015, 33: 1780– 1785. 10.1016/j.vaccine.2015.02.046 25731787 · DOI
  22. [27]Hausdorf K, Newman B, Whiteman D, Aitken J, Frazer I. HPV vaccination: what do Queesland parents think. Australian and New Zealand Journal of Public Health, 2007, 31: 288– 289. 10.1111/j.1467-842X.2007.00066.x. 17682227 · DOI
  23. [28]Cheaper HPV vaccines needed. The Lancet, (3719625): 2008 10.1016/S0140-6736(08)60701-1. 18486723 · DOI
  24. [30]Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, et al Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health, 2008, 43: 239– 245. 10.1016/j.jadohealth.2008.06.009. 18710678 · DOI
  25. [31]Constantine N, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health, 2007, 40: 108– 115. 10.1016/j.jadohealth.2006.10.007. 17259050 · DOI
  26. [32]Marlow LA, Waller J, Wardle J. Trust and experience as predictors of HPV vaccine acceptance ND ES SC RIB marital status ND ES SC. Human Vaccines, 2007, 3: 171– 175. 17622801

Cited by

Sorted by citations

Authors
Yu, Y., Xu, M., Sun, J., Li, R., Li, M., Wang, J., Zhang, D., & Xu, A.
Affiliations
  • Qingdao University (CN)
  • Queensland University of Technology (AU)
  • Shandong University (CN)
Corresponding author
  • Zhang, Dongfeng
  • Xu, Aiqiang
ORCID
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2016-01-14
Volume
11
Issue
1
Pages
e0146741
ISSN
1932-6203 (ISSN-L)
DOI
10.1371/journal.pone.0146741
PMC
PMC4713086
OpenAlex
W2272909281
Cited by
94
References
0
Citations by year
2026: 3 · 2025: 6 · 2024: 10 · 2023: 8 · 2022: 13 · 2021: 7 · 2020: 17 · 2019: 10 · 2018: 12 · 2017: 5 · 2016: 3
FWCI
9.38
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Faculty of Health; Institute of Health and Biomedical Innovation
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
human papillomavirus, HPV vaccination, vaccine acceptance, maternal awareness, maternal knowledge, adolescent girls, cervical cancer prevention, vaccine safety concerns, socioeconomic factors, health education
MeSH terms
Adolescent, Child, China, Female, Humans, Health Knowledge, Attitudes, Practice, Mothers, Papillomavirus Infections, Papillomavirus Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review